Login
$BIIB
$252.26 +$1.57 (0.63%) Close

$BIIB 8-K/A SEC Filings

Filed On Filing
10 Jun 2026 8-K/A: Financial Statements and Exhibits
28 Sep 2023 8-K/A: Submission of Matters to a Vote of Security Holders

As previously reported on the Original Form 8-K, in an advisory vote held at the Annual Meeting on the Say-on-Frequency Proposal, the Company’s stockholders expressed their preference for a Say-on-Pay Vote to be conducted every year. The...

20 Jul 2022 8-K/A: Results of Operations and Financial Condition

Cambridge, Mass. — July 20, 2022 — Biogen Inc. (Nasdaq: BIIB) today reported second quarter 2022 financial results.

12 Feb 2013 8-K/A: Financial Statements and Exhibits
24 Jul 2012 8-K/A: Results of Operations and Financial Condition
01 Feb 2011 8-K/A: Results of Operations and Financial Condition
12 Jan 2004 8-K/A: Financial Statements and Exhibits
25 Nov 2003 8-K/A: Changes in Registrant's Certifying Accountant
03 Oct 2003 8-K/A: Other Events

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support